Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of +52.00% and -12.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Reports Q2 revenue $2.9M, consensus $4.27M. “We’ve made significant progress across our pipeline, with multiple clinical and regulatory milestones ...

Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful ...

In a way, AI models launder human responsibility and human agency through their complexity. When outputs emerge from layers of neural networks processing billions of parameters, researchers can claim ...

Collision Repair Magazine reached out to Opus IVS and asTech for comment; as of publication, no response had been received ...

Alicia Witt reflects on working with Richard Dreyfuss in “Mr. Holland’s Opus,” praising his kindness toward young actors.

Allstate says an email circulating that claims it has a pricing agreement with two tool companies for calibrations is false. ...

The minor twist here is that neither Campbell nor Collins actually has a book deal: Politics and Prose isn’t just selling the ...

OpenAI’s latest AI models are outpacing competitors from Google, Anthropic, xAI, and Meta in keeping their facts straight, ...

Anthropic's popular coding model just became a little more enticing for developers with a million-token context window.

A tech startup wants to replace traditional cement with an eco-friendly alternative, and it just secured the funding to move ...